doi: 10.1038/ncomms14140
Some evidence suggests that oral versions may cause fewer side effects for some people, which could improve long-term tolerability
Retatrutide is a triple receptor agonist that activates GLP-1, GIP, and glucagon receptors, whereas semaglutide targets GLP-1 only and tirzepatide targets GLP-1 and GIP
It is then reduced to its component parts (cytidine and choline), which are incorporated into membranes and microsomes in the central nervous system
Patients from Miami, Miami Beach, Aventura, Sunny Isles Beach, Hollywood, Hallandale Beach, Fort Lauderdale, Boca Raton, Delray Beach, Boynton Beach, West Palm Beach, Jupiter, Plantation, Coral Springs, Davie, Weston, Deerfield Beach, and surrounding communities can discuss peptide therapy options without traveling to the office